In this episode of Petri Dish Perspectives: Biotech Unleashed, we explore the rise of AbbVie, a pharmaceutical giant that emerged from Abbott Laboratories in 2013 and quickly became a leader in immunology, oncology, and aesthetics.
From its blockbuster drug Humira to major acquisitions like Pharmacyclics and Allergan, AbbVie has strategically expanded its portfolio and global presence. We’ll break down the company’s history, key milestones, and the vision driving its future—including cutting-edge research in neuroscience and gene therapy.
Join me as we uncover the science, business moves, and leadership decisions that have shaped AbbVie into one of the most influential players in biotech today.
Grab a coffee and tune in for a fast-paced, insightful breakdown of AbbVie’s journey!
🎧 Listen now, stay curious, and don’t forget to subscribe for new episodes every Thursday!
https://linktr.ee/maneadkhin
© 2025 Petri Dish Perspectives LLC. All rights reserved.
